Org-41793

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOrg-41793
Drug Alias Name3290W93DPI-3290Org-41793DPI-3290W93
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsδ-opioid receptor agonists
TargetsMu opioid receptorδ-opioid receptor
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcEnhance Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganonEnhance BiotechGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A